NL
BSX icon

Navalign LLC’s Boston Scientific BSX Stock Holding History

Navalign LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$495K Buy
11,589
+1,054
+10% +$57.2K 0.12% 91
2026
Q1 		$661K Buy
10,535
+416
+4% +$33.3K 0.17% 80
2025
Q4 		$965K Buy
10,119
+242
+2% +$23.7K 0.24% 68
2025
Q3 		$964K Sell
9,877
-199
-2% -$20.6K 0.25% 66
2025
Q2 		$1.08M Sell
10,076
-1,174
-10% -$119K 0.3% 58
2025
Q1 		$1.13M Sell
11,250
-543
-5% -$54.7K 0.32% 54
2024
Q4 		$1.05M Sell
11,793
-251
-2% -$22.1K 0.31% 55
2024
Q3 		$1.01M Sell
12,044
-385
-3% -$30.3K 0.3% 56
2024
Q2 		$957K Sell
12,429
-20
-0.2% -$1.46K 0.3% 55
2024
Q1 		$853K Sell
12,449
-374
-3% -$24K 0.28% 64
2023
Q4 		$741K Sell
12,823
-292
-2% -$15.6K 0.26% 71
2023
Q3 		$692K Sell
13,115
-490
-4% -$25.7K 0.26% 79
2023
Q2 		$736K Sell
13,605
-714
-5% -$37.3K 0.29% 64
2023
Q1 		$716K Sell
14,319
-289
-2% -$13.6K 0.3% 68
2022
Q4 		$676K Sell
14,608
-802
-5% -$34.7K 0.28% 77
2022
Q3 		$597K Buy
15,410
+616
+4% +$24.7K 0.27% 78
2022
Q2 		$551K Sell
14,794
-24
-0.2% -$977 0.24% 78
2022
Q1 		$638K Buy
14,818
+571
+4% +$24.7K 0.27% 74
2021
Q4 		$605K Buy
14,247
+227
+2% +$9.54K 0.24% 87
2021
Q3 		$608K Sell
14,020
-31
-0.2% -$1.37K 0.26% 85
2021
Q2 		$601K Buy
14,051
+938
+7% +$39.5K 0.25% 82
2021
Q1 		$507K Buy
+13,113
New +$496K 0.22% 91

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Navalign LLC's BSX Position: Q2 2026 in Review

Navalign LLC increased its Boston Scientific (BSX) stake by 10% in Q2 2026, buying an estimated $57.2K and bringing the position to 11,589 shares worth $495K. The position accounts for 0.12% of the portfolio, ranked #91.

Navalign LLC first reported a position in BSX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.13M in Q1 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Navalign LLC held 11,589 shares of Boston Scientific worth $495K as of Q2 2026.
  • Navalign LLC bought 1,054 Boston Scientific shares in Q2 2026, an estimated $57.2K.
  • Boston Scientific made up 0.12% of Navalign LLC's portfolio in Q2 2026, its #91 holding.
  • Navalign LLC first reported a position in Boston Scientific in Q1 2021 and has held it in 22 quarters since.
  • Navalign LLC's Boston Scientific position peaked at $1.13M in Q1 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.